The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
A Comparison of Glyburide and Insulin in Women with Gestational Diabetes Mellitus
Abstract
BACKGROUND: Women with gestational diabetes mellitus are rarely treated with a sulfonylurea drug, because of concern about teratogenicity and neonatal hypoglycemia. There is little information about the efficacy of these drugs in this group of women. METHODS: We studied 404 women with singleton pregnancies and gestational diabetes that required treatment. The women were randomly assigned between 11 and 33 weeks of gestation to receive glyburide or insulin according to an intensified treatment protocol. The primary end point was achievement of the desired level of glycemic control. Secondary end points included maternal and neonatal complications. RESULTS: The mean (+/-SD) pretreatment blood glucose concentration as measured at home for one week was 114+/-19 mg per deciliter (6.4+/-1.1 mmol per liter) in the glyburide group and 116+/-22 mg per deciliter (6.5+/-1.2 mmol per liter) in the insulin group (P=0.33). The mean concentrations during treatment were 105+/-16 mg per deciliter (5.9+/-0.9 mmol per liter) in the glyburide group and 105+/-18 mg per deciliter (5.9+/-1.0 mmol per liter) in the insulin group (P=0.99). Eight women in the glyburide group (4 percent) required insulin therapy. There were no significant differences between the glyburide and insulin groups in the percentage of infants who were large for gestational age (12 percent and 13 percent, respectively); who had macrosomia, defined as a birth weight of 4000 g or more (7 percent and 4 percent); who had lung complications (8 percent and 6 percent); who had hypoglycemia (9 percent and 6 percent); who were admitted to a neonatal intensive care unit (6 percent and 7 percent); or who had fetal anomalies (2 percent and 2 percent). The cord-serum insulin concentrations were similar in the two groups, and glyburide was not detected in the cord serum of any infant in the glyburide group. CONCLUSIONS: In women with gestational diabetes, glyburide is a clinically effective alternative to insulin therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While individual RCTs support limited efficacy of metformin (73,74) and glyburide (75) in reducing glucose levels for the treatment of GDM, these agents are not recommended as the first-line treatment for GDM because they are known to cross the placenta and data on long-term safety for offspring is of some concern (35).”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [75]
In the citing paper
“Although similar glycemic control has been reported with glyburide compared with insulin use,61”
From Gestational Diabetes Mellitus (2019) · cites this paper as [61]
In the citing paper
“Although glyburide was previously thought not to cross the placenta in significant amounts,61 more recent studies using more sensitive assays have demonstrated significant and highly variable transplacental transfer of glyburide.62,63”
From Gestational Diabetes Mellitus (2019) · cites this paper as [61]
Citations
Cites
Criteria for screening tests for gestational diabetes
Carpenter, M. W., & Coustan, D. R. (1982) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(82)90349-0 · Cited by 1,924
Rossetti, L., Giaccari, A., & DeFronzo, R. A. (1990) · Diabetes Care · doi:10.2337/diacare.13.6.610 · Cited by 770
Rouse, D. J. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540180036030 · Cited by 496
Oates, J. A., Wood, A. J. J., & Gerich, J. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911023211805 · Cited by 480
Intensified versus conventional management of gestational diabetes
Langer, O., Rodriguez, D. A., Xenakis, E. M. J., McFarland, M. B., Berkus, M. D., & Arredondo, F. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(94)70097-4 · Cited by 392
Self-citationLanger, O., Levy, J., Brustman, L., Anyaegbunam, A., Merkatz, R., & Divon, M. (1989) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(89)90371-2 · Cited by 376
Self-citationInsignificant transfer of glyburide occurs across the human placenta
Elliott, B. D., Langer, O., Schenker, S., & Johnson, R. F. (1991) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(91)90421-m · Cited by 260
Self-citationElliott, B. D., Schenker, S., Langer, O., Johnson, R., & Prihoda, T. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(94)90078-7 · Cited by 250
Self-citationCorbet, A., Bucciarelli, R., Goldman, S., Mammel, M., Wold, D., & Long, W. (1991) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)80502-5 · Cited by 201
Metformin in management of pregnant insulin-independent diabetics
Coetzee, E. J., & Jackson, W. P. U. (1979) · Diabetologia · doi:10.1007/bf01221950 · Cited by 178
Research works printed but not linked: 11
- Diabetes and pregnancy. ACOG technical bulletin. No. 200 (replaces no. 92). Washington, D.C.: American College of Obstetricians and Gynecologists, December 1994:359-66.
- 1998, Diabetes Care, 21, B161
- Lebovitz HE, 1999, Diabetes Rev, 7, 139
- Farquhar JW, 1968, S Afr Med J, 42, 237
- Smoak IW, 1992, Teratology, 45, 474
- Jackson WPU, 1962, Diabetes, 11, 98
- Coetzee EJ, 1984, S Afr Med J, 65, 635
- Coetzee EJ, 1980, S Afr Med J, 15, 795
- Dolger H, 1962, Diabetes, 11, 97
- Notelovitz M, 1971, S Afr Med J, 45, 226
- 1974, Lancet, 2, 32
Cited by
Buchanan, T. A., & Xiang, A. H. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524531 · Cited by 2,123
Metzger, B. E., Buchanan, T. A., Coustan, D. R., de Leiva, A., Dunger, D. B., Hadden, D. R., Hod, M., Kitzmiller, J. L., Kjos, S. L., Oats, J. N., et al. (2007) · Diabetes Care · doi:10.2337/dc07-s225 · Cited by 1,908
McIntyre, H. D., Catalano, P., Zhang, C., Desoye, G., Mathiesen, E. R., & Damm, P. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0098-8 · Cited by 1,850
ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus
(2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002501 · Cited by 1,820
Practice Bulletin No. 183: postpartum hemorrhage
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002351 · Cited by 1,406
Metadata
- Authors
- Langer, O., Conway, D. L., Berkus, M. D., Xenakis, E. M.-J., & Gonzales, O.
- Affiliations
- St. Luke's-Roosevelt Hospital Center (US)
- The University of Texas at San Antonio Health Science Center (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2000-10-19
- Volume
- 343
- Issue
- 16
- Pages
- 1134-1138
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2326851691
- Cited by
- 924
- References
- 41
- Citations by year
- 2026: 14 · 2025: 11 · 2024: 13 · 2023: 13 · 2022: 18 · 2021: 42 · 2020: 24 · 2019: 23 · 2018: 45 · 2017: 97 · 2016: 47 · 2015: 61 · 2014: 38 · 2013: 44 · 2012: 37
- FWCI
- 27.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- gestational diabetes mellitus, glibenclamide, insulin therapy, sulfonylureas, glycemic control, neonatal hypoglycemia, macrosomia, fetal malformations, teratogenicity, neonatal intensive care admission
- MeSH terms
- Congenital Abnormalities, Adolescent, Adult, Blood Glucose, Female, Fetal Blood, Fetal Macrosomia, Glyburide, Humans, Hypoglycemia, Hypoglycemic Agents, Infant, Newborn, Insulin, Pregnancy, Pregnancy Outcome, Diabetes, Gestational
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Comparison of Glyburide and Insulin in Women with Gestational Diabetes Mellitus. https://app.cochat.ai/papers/10.1056/nejm200010193431601
- The paper
- Langer, O., Conway, D. L., Berkus, M. D., Xenakis, E. M.-J., & Gonzales, O. (2000). A Comparison of Glyburide and Insulin in Women with Gestational Diabetes Mellitus. New England Journal of Medicine. https://doi.org/10.1056/nejm200010193431601
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.